GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Synektik SA (STU:A2P) » Definitions » Cash Flow from Financing

Synektik (STU:A2P) Cash Flow from Financing : €-8.2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Synektik Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, Synektik paid €0.0 Mil more to buy back shares than it received from issuing new shares. It received €0.0 Mil from issuing more debt. It paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received €0.0 Mil from paying cash dividends to shareholders. It spent €0.1 Mil on other financial activities. In all, Synektik spent €0.1 Mil on financial activities for the three months ended in Dec. 2024.


Synektik Cash Flow from Financing Historical Data

The historical data trend for Synektik's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synektik Cash Flow from Financing Chart

Synektik Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.24 -1.73 -2.76 0.53 -7.87

Synektik Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -6.91 -0.37 -0.48 -0.46

Synektik Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Synektik's Cash from Financing for the fiscal year that ended in Sep. 2023 is calculated as:

Synektik's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synektik  (STU:A2P) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Synektik's issuance of stock for the three months ended in Dec. 2024 was €0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Synektik's repurchase of stock for the three months ended in Dec. 2024 was €0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Synektik's net issuance of debt for the three months ended in Dec. 2024 was €0.0 Mil. Synektik received €0.0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Synektik's net issuance of preferred for the three months ended in Dec. 2024 was €0.0 Mil. Synektik paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Synektik's cash flow for dividends for the three months ended in Dec. 2024 was €0.0 Mil. Synektik received €0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Synektik's other financing for the three months ended in Dec. 2024 was €-0.1 Mil. Synektik spent €0.1 Mil on other financial activities.


Synektik Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Synektik's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Synektik Business Description

Traded in Other Exchanges
Address
Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.

Synektik Headlines

No Headlines